Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Filings indexed 777 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Chair's Address to Shareholders 5 pages 273.8KB
Regulatory Filings
2026-05-07 English
Managing Director's Address to Shareholders 12 pages 275.3KB
Regulatory Filings
2026-05-07 English
CYC 2026 AGM Presentation 38 pages 4.4MB
Regulatory Filings
2026-05-07 English
Results of Meeting 2 pages 219.3KB
Regulatory Filings
2026-05-07 English
Final Director's Interest Notice - DH 2 pages 187.4KB
Regulatory Filings
2026-05-07 English
Final Director's Interest Notice - KB 2 pages 188.0KB
Regulatory Filings
2026-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.